Assesses thermal stability in tagged and untagged amyloid precursor protein E2 domain, suggesting tag removal is unnecessary for ligand screening.
The amyloid precursor protein, central to the pathology of several disease including Alzheimer’s disease, cancer and obesity, represents a therapeutic target. Being able to screen amyloid precursor protein, and its domains, in rapid high-throughput assays could advance drug discovery efforts. The purpose of this study was to determine if removal of a C-terminal tag from the amyloid precursor protein E2 domain was necessary for ligand screening using differential scanning fluorometry. To this end, we assessed both the thermal stability and metal-ion binding propensity in both the tagged and untagged protein. The C-terminal myc-6xHis-tag does not impact the amyloid precursor protein E2 domain thermal stability with comparable melting temperatures of 59.4 °C and 59.1 °C in sodium phosphate buffer, for tagged and untagged protein, respectively. Additionally, the tag had no influence on the ability of the metal-ions, Zn 2+ and Cu 2+ , to shift the thermal stability of the E2 domain indicating that metal-ion binding is not influenced by the tag. We therefore suggest that it is not necessary to remove the C-terminal tag from the E2 domain for ligand screening using differential scanning fluorometry.
No takes yet. Share an insight, caveat, or question.
Nxele et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: